BILLS-104hr1021ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (2)
1995
FEBRUARY 23, 1995
EVENT (2)
the ‘‘Blood Products
SESSION
H. R. 1021
GPE (4)
Florida
Maryland
Pennsylvania
the United States of America
ORG (12)
Blood Products Advisory Committee
Health and Human Services
SEC
the Blood Products Advisory
Drug Administration
the Food and Drug Administration
Congress
THE HOUSE OF REPRESENTATIVES
Senate
House of Representa-
the Committee on Commerce
PERSON (14)
NADLER
ENGLISH
MEEK
GEJD-
ENSON
GOSS
QUILLEN
BARTLETT
FURSE
HILLIARD
CALVERT
MARKEY
FOWLER
STEARNS
ENGEL
Topic Classifications
congressional legislation
96.9%
government oversight
51.0%
public health
32.1%
Extracted Keywords
blood
products
representation
advisory committee
consumer
advisory
secretary health
voting
drug administration
human services
health human
require secretary
food drug
human
drug
Forensic Analysis
PDF Metadata
- ModDate
- D:20230118183341Z
- Producer
- Acrobat Net Distiller 1.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
Sentiment
Polarity
Neutral
-0.014
Subjectivity
18%
Objective